Zymeworks (NYSE: ZYME) reported Q2 EPS of ($0.97), $0.02 worse than the analyst estimate of ($0.95). Revenue for the quarter came in at $5.44 million versus the consensus estimate of $7.09 million.

For earnings history and earnings-related data on Zymeworks (ZYME) click here.